HDSN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Hudson Technologies is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a mildly constructive setup technically and analysts still rate it Buy, but the near-term price action is not decisive, the earnings date is very close, and the latest financials show revenue growth but poor profitability and collapsing gross margin. Since there is no strong Intellectia signal today and no fresh news catalyst, I would not call this an immediate buy. Best direct call: hold and wait for a cleaner entry.
HDSN is trading pre-market at 6.26, essentially right at pivot support (6.268). RSI_6 at 52.4 is neutral, MACD histogram is slightly positive but contracting, and moving averages are converging, which points to a flat-to-mixed trend rather than a strong breakout. Support sits near 6.07 and 5.95, while resistance is 6.46 and 6.58. The short-term pattern data is bearish, implying downside pressure over the next day/week/month, so the technical picture does not favor an urgent long-term buy today.
["Revenue in 2025/Q4 rose 28.19% YoY, showing solid top-line growth.", "Analyst coverage remains supportive, with both Canaccord and B. Riley keeping Buy ratings.", "The business saw strong volume execution and reclamation volume growth, which supports the core operating thesis.", "No recent negative news was reported in the last week."]
["No news catalysts in the recent week, so there is no fresh event-driven upside driver.", "Gross margin fell sharply to 6.12, indicating profitability pressure despite higher revenue.", "Net income remains negative at -8.63M and EPS is still negative.", "Price target cuts from $10-$10.50 down to $9.50 suggest reduced upside expectations.", "Pattern-based trend analysis implies near-term downside risk.", "Earnings are scheduled for 2026-05-06 after hours, which may keep buyers cautious before the report.", "No notable insider, hedge fund, or congress trading activity was reported recently."]
Latest quarter shown is 2025/Q4. Revenue increased to $44.41M, up 28.19% YoY, which is a healthy growth signal. However, the company still posted a net loss of -$8.63M and EPS of -$0.20, even though both improved year over year. The main weakness is gross margin, which dropped to 6.12, down 55.39% YoY, showing that growth is not yet translating into strong earnings quality.
Analysts remain constructive overall, but the tone has softened. Canaccord lowered its price target to $9.50 from $10 while keeping a Buy rating, and B. Riley cut its target to $9.50 from $10.50 and also kept Buy. The pros view is that core execution and reclamation volume growth remain healthy. The cons view is weak near-term pricing power and lower margin quality, which is why targets were reduced. Overall Wall Street stance is still bullish, but with less upside confidence than before.
